NCCN Guidelines® Insights Malignant Pleural Mesothelioma, Version 3.2016 Featured Updates to the NCCN Guidelines

被引：76

作者：

Ettinger, David S. ^{[1
]}

Wood, Douglas E. ^{[2
]}

Akerley, Wallace ^{[3
]}

Bazhenova, Lyudmila A. ^{[4
]}

Borghaei, Hossein ^{[5
]}

Camidge, David Ross ^{[6
]}

Cheney, Richard T. ^{[7
]}

Chirieac, Lucian R. ^{[8
]}

D'Amico, Thomas A. ^{[9
]}

Dilling, Thomas ^{[10
]}

Dobelbower, Michael ^{[11
]}

Govindan, Ramaswamy ^{[12
,13
]}

Hennon, Mark ^{[7
]}

Horn, Leora ^{[14
]}

Jahan, Thierry M. ^{[15
]}

Komaki, Ritsuko ^{[16
]}

Lackner, Rudy P. ^{[17
]}

Lanuti, Michael ^{[18
]}

Lilenbaum, Rogerio ^{[19
]}

Lin, Jules ^{[20
]}

Loo, Billy W., Jr. ^{[21
]}

Martins, Renato ^{[2
]}

Otterson, Gregory A. ^{[22
,23
]}

Patel, Jyoti D. ^{[24
]}

Pisters, Katherine M. ^{[16
]}

Reckamp, Karen ^{[25
]}

Riely, Gregory J. ^{[26
]}

Schild, Steven E. ^{[27
]}

Shapiro, Theresa A. ^{[1
]}

Sharma, Neelesh ^{[28
,29
,30
]}

Swanson, Scott J. ^{[8
]}

Stevenson, James ^{[28
,29
,30
]}

Tauer, Kurt ^{[31
]}

Yang, Stephen C. ^{[1
]}

Gregory, Kristina ^{[32
]}

Hughes, Miranda ^{[32
]}

机构：

[1] Johns Hopkins, Sidney Kimmel Comprehens Canc Ctr, Baltimore, MD 21287 USA

[2] Fred Hutchinson Canc Res Ctr, Seattle Canc Care Alliance, Seattle, WA USA

[3] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT 84112 USA

[4] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[5] Fox Chase Canc Ctr, Philadelphia, PA USA

[6] Univ Colorado, Ctr Canc, Boulder, CO 80309 USA

[7] Roswell Pk Canc Inst, Buffalo, NY USA

[8] Dana Farber Brigham & Womens Canc Ctr, Boston, MA USA

[9] Duke Canc Inst, Durham, NC USA

[10] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[11] Univ Alabama, Birmingham Comprehens Canc Ctr, Tuscaloosa, AL 35487 USA

[12] Barnes Jewish Hosp, Siteman Canc Ctr, St Louis, MO USA

[13] Washington Univ, Sch Med, St Louis, MO 63130 USA

[14] Vanderbilt Ingram Canc Ctr, Nashville, TN USA

[15] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[16] Univ Texas MD Anderson Canc Ctr, Houston, TX USA

[17] Fred & Pamela Buffett Canc Ctr, Omaha, NE USA

[18] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA

[19] Yale Canc Ctr, Smilow Canc Hosp, New Haven, CT USA

[20] Univ Michigan, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA

[21] Stanford Canc Inst, Stanford, CA USA

[22] Ohio State Univ, Ctr Comprehens Canc, James Canc Hosp, Columbus, OH 43210 USA

[23] Ohio State Univ, Solove Res Inst, Columbus, OH 43210 USA

[24] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[25] City Hope Natl Med Ctr, Ctr Comprehens Canc, Duarte, CA USA

[26] Mem Sloan Kettering Canc Ctr, New York, NY USA

[27] Mayo Clin, Ctr Canc, Rochester, MN USA

[28] Case Comprehens Canc Ctr, Cleveland, OH USA

[29] Univ Hosp Seidman Canc Ctr, Cleveland, OH USA

[30] Cleveland Clin Taussig Canc Inst, Cleveland, OH USA

[31] Univ Tennessee, Hlth Sci Ctr, St Jude Childrens Res Hosp, Knoxville, TN 37996 USA

[32] Natl Comprehens Canc Network, Ft Washington, MD USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2016年 / 14卷 / 07期

关键词：

PEMETREXED PLUS CISPLATIN; MULTICENTER PHASE-II; LONG-TERM SURVIVAL; EXTRAPLEURAL PNEUMONECTOMY; TRIMODALITY THERAPY; PLEURECTOMY-DECORTICATION; NEOADJUVANT CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; SURGICAL-MANAGEMENT; RADICAL PLEURECTOMY;

D O I：

10.6004/jnccn.2016.0087

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

These NCCN Guidelines Insights focus on recent updates to the NCCN Guidelines for Malignant Pleural Mesothelioma (MPM). These NCCN Guidelines Insights discuss systemic therapy regimens and surgical controversies for MPM. The NCCN panel recommends cisplatin/pemetrexed (category1) for patients with MPM. The NCCN panel also now recommends bevacizumab/cisplatin/pemetrexed as a first-line therapy option for patients with unresectable MPM who are candidates for bevacizumab. The complete version of the NCCN Guidelines for MPM, available at NCCN. org, addresses all aspects of management for MPM including diagnosis, evaluation, staging, treatment, surveillance, and therapy for recurrence and metastasis; NCCN Guidelines are intended to assist with clinical decision-making.

引用

页码：825 / 836

页数：12

共 104 条

[1] Systemic therapy options for malignant pleural mesothelioma beyond first-line therapy: a systematic review [J].

Abdel-Rahman, Omar ;

Kelany, Mohamed .

EXPERT REVIEW OF RESPIRATORY MEDICINE, 2015, 9 (05) :533-549

[2] Current Issues in Malignant Pleural Mesothelioma Evaluation and Management [J].

Ai, Jing ;

Stevenson, James P. .

ONCOLOGIST, 2014, 19 (09) :975-984

[3] Clinical safety and efficacy of pembrolizumab (MK-3475) in patients with malignant pleural mesothelioma: Preliminary results from KEYNOTE-028 [J].

Alley, Evan Ni ;

Molife, L. Rhoda ;

Santoro, Armando ;

Beckey, Kim ;

Yuan, Sammy ;

Cheng, Jonathan D. ;

Piperdi, Bilal ;

Schellens, Johannes H. M. .

CANCER RESEARCH, 2015, 75

[4]

Alley EW, 2016, 16 WORLD C LUNG CANC

[5] MALIGNANT MESOTHELIOMA FOLLOWING RADIATION EXPOSURE [J].

ANTMAN, KH ;

CORSON, JM ;

LI, FP ;

GREENBERGER, J ;

SYTKOWSKI, A ;

HENSON, DE ;

WEINSTEIN, L .

JOURNAL OF CLINICAL ONCOLOGY, 1983, 1 (11) :695-700

[6] A phase II trial of prolonged, continuous infusion of low-dose gemcitabine plus cisplatin in patients with advanced malignant pleural mesothelioma [J].

Arrieta, Oscar ;

Lopez-Macias, Diego ;

Mendoza-Garcia, Victor-Osvaldo ;

Bacon-Fonseca, Ludwing ;

Munoz-Montano, Wendy ;

Macedo-Perez, Eleazar-Omar ;

Muniz-Hernandez, Sae ;

Blake-Cerda, Monika ;

Corona-Cruz, Jose-Francisco .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (05) :975-982

[7] Should We Continue to Offer Extrapleural Pneumonectomy to Selected Mesothelioma Patients? A Single Center Experience Comparing Surgical and Non-surgical Management [J].

Baud, Mariette ;

Bobbio, Antonio ;

Lococo, Filippo ;

Regnard, Jean-Francois ;

Alifano, Marco .

JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (11) :1127-1129

[8] Induction chemotherapy, extrapleural pneumonectomy, and adjuvant radiotherapy for malignant pleural mesothelioma: Experience of Guy's and St Thomas' hospitals [J].

Bille A. ;

Belcher E. ;

Raubenheimer H. ;

Landau D. ;

Cane P. ;

Spicer J. ;

Lang-Lazdunski L. .

General Thoracic and Cardiovascular Surgery, 2012, 60 (5) :289-296

[9]

Blomberg C, 2015, ANTICANCER RES, V35, P2493

[10] Radical pleurectomy and chemoradiation for malignant pleural mesothelioma: The outcome of incomplete resections [J].

Boeluekbas, Servet ;

Eberlein, Michael ;

Fisseler-Eckhoff, Annette ;

Schirren, Joachim .

LUNG CANCER, 2013, 81 (02) :241-246

← 1 2 3 4 5 6 7 8 9 10 →